|
1
|
Dai Y, Sun L, Tan Y, Xu W, Liu S, Zhou J, Hu Y, Lin J, Yao X, Mi P, Zheng X. Recent progress in the development of ursolic acid derivatives as anti-diabetes and anti-cardiovascular agents. Chem Biol Drug Des 2023; 102:1643-1657. [PMID: 37705131 DOI: 10.1111/cbdd.14347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 08/20/2023] [Accepted: 08/30/2023] [Indexed: 09/15/2023]
Abstract
Ursolic acid (UA) is a pentacyclic triterpenoid, which exhibits many biological activities, particularly in anti-cardiovascular and anti-diabetes. The further application of UA is greatly limited due to its low bioavailability and poor water solubility. Up to date, various UA derivatives have been designed to overcome these shortcomings. In this paper, the authors reviewed the development of UA derivatives as the anti-diabetes anti-cardiovascular reagents.
Collapse
Affiliation(s)
- Yili Dai
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Linjun Sun
- Department of Pharmacy, Hunan Vocational College of Science and Technology, Changsha, China
| | - Yan Tan
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Wenyu Xu
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Shu Liu
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Jing Zhou
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Yalin Hu
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Jieying Lin
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Xu Yao
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Pengbing Mi
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
| | - Xing Zheng
- Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China
- Department of Pharmacy, Hunan Vocational College of Science and Technology, Changsha, China
| |
Collapse
|
|
2
|
Erdmann J, Kujaciński M, Wiciński M. Beneficial Effects of Ursolic Acid and Its Derivatives-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions. Nutrients 2021; 13:3900. [PMID: 34836155 PMCID: PMC8622438 DOI: 10.3390/nu13113900] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 10/26/2021] [Accepted: 10/29/2021] [Indexed: 12/13/2022] Open
Abstract
Ursolic acid (UA) is a natural pentacyclic triterpenoid found in a number of plants such as apples, thyme, oregano, hawthorn and others. Several in vitro and in vivo studies have presented its anti-inflammatory and anti-apoptotic properties. The inhibition of NF-κB-mediated inflammatory pathways and the increased scavenging of reactive oxygen species (ROS) in numerous ways seem to be the most beneficial effects of UA. In mice and rats, administration of UA appears to slow down the development of cardiovascular diseases (CVDs), especially atherosclerosis and cardiac fibrosis. Upregulation of endothelial-type nitric oxide synthase (eNOS) and cystathionine-λ-lyase (CSE) by UA may suggest its vasorelaxant property. Inhibition of metalloproteinases activity by UA may contribute to better outcomes in aneurysms management. UA influence on lipid and glucose metabolism remains inconsistent, and additional studies are essential to verify its efficacy. Furthermore, UA derivatives appear to have a beneficial impact on the cardiovascular system. This review aims to summarize recent findings on beneficial effects of UA that may make it a promising candidate for clinical trials for the management of CVDs.
Collapse
Affiliation(s)
- Jakub Erdmann
- Department of Pharmacology and Therapeutics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, M. Curie 9, 85-090 Bydgoszcz, Poland; (M.K.); (M.W.)
| | | | | |
Collapse
|